Posters

      Development of a tobacco and nicotine products dependence instrument

      Chrea, C.; Salzberger, T.; Abetz-Webb, L.; Afolalu, E.; Cano, S.; Rose, J.; Weitkunat, R.; Fagerström, K.
      Conference date
      Feb 24, 2018
      Conference name
      Society for Research on Nicotine and Tobacco (SRNT) 2018
      Link to more information
      Link to more information
      Topic
      Summary

      No abstract available.

      Related Publications

      How do Risk Perceptions Drive Smokers to Completely Switch to a Smoke-Free Tobacco Product (IQOS™)? A Four-Country Cohort Study

      Perception and Behavior

      Immediate test-retest reliabilities of intention to quit smoking measures in current adult smokers

      Perception and Behavior

      Perceived Reduced Formation of Harmful Chemicals (RF) and Perceived Reduced Risk of Harm (RH) Impact Exclusive Use of Heated Tobacco Product IQOS: A Prospective Consumer Cohort Study in Four Culturally and Socio-Economically Different Countries

      Perception and Behavior

      Risk Perception of IQOS: Evidence from Japan's rolling post market cross sectional surveys

      Perception and Behavior

      Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons

      Perception and Behavior

      Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons

      Perception and Behavior

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.